Notice: This CMS-approved document has been submitted - Philips ...
Notice: This CMS-approved document has been submitted - Philips ... Notice: This CMS-approved document has been submitted - Philips ...
CMS-1403-FC provisions due to the alleged economic losses and decreased operating efficiencies that will result. The commenters contended that the fact that the diagnostic equipment is located in a separate building does not support an inference that the diagnostic services are not an integral part of the practice, as our proposal assumes. Response: Under this final rule, the anti-markup provisions will not apply to the TC or PC of a diagnostic test where the performing physician shares a practice with the billing physician or other supplier. With respect to a TC or PC of a diagnostic testing service, the performing physician is considered to share a practice with the billing physician or other supplier if: (1) he or she furnishes substantially all (at least 75 percent) of his or her professional services through the billing physician or other supplier; or (2) the TC is conducted and supervised, or the PC is performed, in the office of the billing physician or other supplier. We believe that, in the situation where an arrangement would otherwise be subject to the anti-markup payment limitation because the performing physician does not furnish at least 75 percent of his or her professional services through the billing physician or other supplier, services that satisfy the site-of-service approach indicate a sufficient nexus 482
CMS-1403-FC between the performing physician and the billing physician or other supplier. We proposed clarifying that the “office of the billing physician or other supplier” protects diagnostic testing that takes place in the “same building” (as defined at §411.351) in which the ordering physician sees patients because, following publication of the CY 2008 PFS final rule with comment period, stakeholders expressed concern that arrangements in which the diagnostic testing takes place on one floor of a building, but the billing physician or other supplier sees patients on another floor, could be subject to the anti-markup provisions. We agree with those stakeholders that it would be unnecessarily disruptive to impose the anti-markup payment limitation on those types of arrangements, but we do not believe that it is appropriate to go further and define “office of the billing physician or other supplier” as including diagnostic testing space that is in a separate building from where the ordering physician sees patients. Specifically, we are unwilling to define “office of the billing physician or other supplier” as including diagnostic testing space in a “centralized building” due to the potential overbreadth of that definition with respect to some arrangements. We also reject a square footage test in lieu of using the “same building” definition because the 483
- Page 431 and 432: CMS-1403-FC would be simpler to not
- Page 433 and 434: CMS-1403-FC IDTF standards in §410
- Page 435 and 436: CMS-1403-FC that rule, the Governme
- Page 437 and 438: CMS-1403-FC with comment period, th
- Page 439 and 440: CMS-1403-FC 1842(n)(1) of the Act,
- Page 441 and 442: CMS-1403-FC anti-markup provisions
- Page 443 and 444: CMS-1403-FC her group practice woul
- Page 445 and 446: CMS-1403-FC A commenter representin
- Page 447 and 448: CMS-1403-FC tenens arrangements cou
- Page 449 and 450: CMS-1403-FC other supplier. We are
- Page 451 and 452: CMS-1403-FC on pathology reports or
- Page 453 and 454: CMS-1403-FC patients. According to
- Page 455 and 456: CMS-1403-FC from sharing a practice
- Page 457 and 458: CMS-1403-FC Group A orders the TC a
- Page 459 and 460: CMS-1403-FC physicians the flexibil
- Page 461 and 462: CMS-1403-FC Response: We recognize
- Page 463 and 464: CMS-1403-FC Response: Because the d
- Page 465 and 466: CMS-1403-FC limited by the proposed
- Page 467 and 468: CMS-1403-FC Response: With respect
- Page 469 and 470: CMS-1403-FC to focus on the medical
- Page 471 and 472: CMS-1403-FC service” approach bec
- Page 473 and 474: CMS-1403-FC have the right to recei
- Page 475 and 476: CMS-1403-FC 2 approach finalized he
- Page 477 and 478: CMS-1403-FC the ordering physician
- Page 479 and 480: CMS-1403-FC ensure an adequate nexu
- Page 481: CMS-1403-FC entity” should be def
- Page 485 and 486: CMS-1403-FC supplier” to encompas
- Page 487 and 488: CMS-1403-FC to continue to provide
- Page 489 and 490: CMS-1403-FC requirements of the Alt
- Page 491 and 492: CMS-1403-FC supervised in the offic
- Page 493 and 494: CMS-1403-FC reducing access to care
- Page 495 and 496: CMS-1403-FC commenter supported ado
- Page 497 and 498: CMS-1403-FC “outside supplier,”
- Page 499 and 500: CMS-1403-FC group could recover onl
- Page 501 and 502: CMS-1403-FC incurred, thereby compe
- Page 503 and 504: CMS-1403-FC needed to provide the t
- Page 505 and 506: CMS-1403-FC performing supplier for
- Page 507 and 508: CMS-1403-FC providers, the services
- Page 509 and 510: CMS-1403-FC commenter also expresse
- Page 511 and 512: CMS-1403-FC overutilization of in-o
- Page 513 and 514: CMS-1403-FC provisions for single-s
- Page 515 and 516: CMS-1403-FC we did not propose such
- Page 517 and 518: CMS-1403-FC and PCs supervised or p
- Page 519 and 520: CMS-1403-FC provisions will not app
- Page 521 and 522: CMS-1403-FC (Pub. L. 110-173) (MMSE
- Page 523 and 524: CMS-1403-FC reporting data on quali
- Page 525 and 526: CMS-1403-FC PQRI and a more detaile
- Page 527 and 528: CMS-1403-FC and our responses to th
- Page 529 and 530: CMS-1403-FC provisions of the Priva
- Page 531 and 532: CMS-1403-FC reducing eligible profe
<strong>CMS</strong>-1403-FC<br />
provisions due to the alleged economic losses and decreased<br />
operating efficiencies that will result. The commenters<br />
contended that the fact that the diagnostic equipment is<br />
located in a separate building does not support an<br />
inference that the diagnostic services are not an integral<br />
part of the practice, as our proposal assumes.<br />
Response: Under this final rule, the anti-markup<br />
provisions will not apply to the TC or PC of a diagnostic<br />
test where the performing physician shares a practice with<br />
the billing physician or other supplier. With respect to a<br />
TC or PC of a diagnostic testing service, the performing<br />
physician is considered to share a practice with the<br />
billing physician or other supplier if: (1) he or she<br />
furnishes substantially all (at least 75 percent) of his or<br />
her professional services through the billing physician or<br />
other supplier; or (2) the TC is conducted and supervised,<br />
or the PC is performed, in the office of the billing<br />
physician or other supplier. We believe that, in the<br />
situation where an arrangement would otherwise be subject<br />
to the anti-markup payment limitation because the<br />
performing physician does not furnish at least 75 percent<br />
of his or her professional services through the billing<br />
physician or other supplier, services that satisfy the<br />
site-of-service approach indicate a sufficient nexus<br />
482